Healton C, Taylor S, Burr C, Dumois A, Loewenstein N, Kaye J
Division of Sociomedical Sciences, Columbia School of Public Health, Columbia University, New York, New York 10032, USA.
Am J Prev Med. 1996 Jul-Aug;12(4 Suppl):47-52.
The termination of the perinatal HIV transmission trial, ACTG 076, by the Data Safety and Monitoring Board in February 1994 because of the efficacy of zidovudine (ZDV) in substantially reducing maternal-infant HIV transmission has created a considerable need for efficacious patient education approaches and materials for women with and at risk of HIV infection. Complexities surrounding patients' decisions to use ZDV in accordance with the treatment arm protocol of this study must be communicated to women, especially the consequences for both themselves and their potential children. In March 1994, a public-private partnership was formed to develop and test the impact of patient education information on 076 and to explore cultural differences in decision-making surrounding ZDV use during pregnancy. Objectives were (1) to develop an efficacious patient informational booklet on the results of ACTG 076 and (2) to determine the differential attitudes and behavioral intentions of women toward taking AZT during pregnancy. A multi-disciplinary group of providers and researchers developed the patient education booklet and field-tested it in five New York City area sites. Subjects were a multiethnic group of women of childbearing age who were predominantly HIV-positive or at risk of HIV infection (n = 120). This 076 education resulted in a substantial increase in intention to use ZDV to reduce perinatal transmission despite full disclosure of the unknowns (P < .001). There were differences in knowledge acquired between racial/ethnic groups, which must be viewed cautiously since the study did not assess socioeconomic status adequately. Attitudes toward ZDV (P < .05), trust in health care providers (P < .03), and opinions on whether testing should be voluntary (P < .02) also varied by race/ethnicity. Medical Subject Headings (MeSH): perinatal transmission, AIDS education, pregnancy, HIV, ACTG 076.
1994年2月,数据安全与监测委员会终止了围产期HIV传播试验(ACTG 076),原因是齐多夫定(ZDV)在大幅降低母婴HIV传播方面具有疗效,这使得迫切需要为感染HIV和有感染风险的女性提供有效的患者教育方法和材料。必须向女性传达围绕患者按照本研究治疗组方案使用ZDV的决定的复杂性,尤其是对她们自身及其潜在子女的影响。1994年3月,建立了公私合作伙伴关系,以开发和测试患者教育信息对076的影响,并探讨孕期使用ZDV决策中的文化差异。目标是:(1)编写一本关于ACTG 076结果的有效患者信息手册;(2)确定女性在孕期服用齐多夫定(AZT)的不同态度和行为意向。一个由提供者和研究人员组成的多学科小组编写了患者教育手册,并在纽约市地区的五个地点进行了实地测试。受试者是一群育龄多民族女性,她们大多为HIV阳性或有感染HIV的风险(n = 120)。尽管充分披露了未知因素,但这种076教育使使用ZDV减少围产期传播的意向大幅增加(P <.001)。种族/族裔群体之间获得的知识存在差异,由于该研究未充分评估社会经济地位,因此必须谨慎看待这一差异。对ZDV的态度(P <.05)、对医疗保健提供者的信任(P <.03)以及对检测是否应自愿的看法(P <.02)也因种族/族裔而异。医学主题词(MeSH):围产期传播、艾滋病教育、妊娠、HIV、ACTG 076。